Stock Detail
AUXILIUM PHARMACEUTICALS INC
Drug Related Products
AUXL @ Yahoo Finance | AUXL Option @ Yahoo Finance
Last Day's Data
| Current Price | High | Value Change | Percent Change | Dividend | Previous Close |
|---|---|---|---|---|---|
| $16.90 | $17.09 | $1.01 | 6.36% | 0.00 | $15.89 |
| Opening Price | Low | Volume | Market Cap | Average Volume | P/E |
| $15.78 | $15.52 | 1,000,000 | 810.34M | 825,307.33 | -21.67 |
Pivot Table
| R2 | R1 | Pivot | S1 | S2 |
| 18.07 | 17.48 | 16.50 | 15.91 | 14.93 |
Stock Profile
Auxilium Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products for urologic and sexual health disorders. The company markets, Testim, a proprietary, topical 1% testosterone gel indicated for the treatment of hypogonadism. The company's product development pipeline includes AA4500 for the treatment of Peyronie's Disease; a product for the treatment of hypogonadism; and a treatment for overactive bladder, a medical condition affecting both men and women characterized by urinary urgency and increased frequency of urination. Auxilium was founded by Gerri A. Henwood and Jane H. Hollingsworth in 1999. The company was formerly known as Auxilium A2, Inc. and changed its name to Auxilium Pharmaceuticals, Inc. in 2002. Auxilium is headquartered in Norristown, Pennsylvania.